Evidence Hub

2023 International Conference on Mental Health and Behavioral Medicine (MHBM2023)

Medicine, 2024

1 citation

Abstract

MHBM001: LURASIDONE CAN RELIEVE THE PROLONGED QTC INTERVAL DURING TREATMENT: A CASE REPORT Cunbo Wua, Kexiang Chenga, Yuan Lia, Xiaolin Tana aChongqing Mental Health Center, Gele Mountain, Shapingba District, Chongqing, 400036, China. Background: As one of the second-generation new antipsychotics approved by the US FDA from 2009 to 2010, lurasidone does not affect QTc interphase and has little effect on metabolism, improve the cognitive function,,so it is well received in clinical practice and has established a unique position in schizophrenia and bipolar disorder. In patients with schizophrenia, taking other antipsychotics can lead to a prolonged QTc interval. At this point, lurasidone becomes the preferred choice for schizophrenia patients with prolonged QTc interval. Subjects and methods: A 75-year-old elderly woman with schizophrenia, such as soliloquy, nonsense, behavior disorder, suspected of being a victim, suspected of stealing, such that Emotional response is not coordinated, after admission to talk about their illness a straight face with a smile, talking about the death of their loved ones laughing, behavior disorder, at home disorderly water mop, lying in bed for a long time closed eyes, often kneeling on the ground to pray to God, there is yelling during night sleep, sometimes at home, pushing, scolding her husband, mumbling, repeatedly pouring water at home mopping the floor, washing hair with cold water many times a day without blowing, closing your eyes for a…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free